VEGFA and neoplasm: An interesting approach of combining miRNA-based therapeutics to inhibit angiogenesis is evident from a study of Lee et al. Runt-related transcription factor 3 (RUNX3) is involved in the destabilization of HIF1α—a major inducer of VEGF production—and thereby prevents tumor angiogenesis [78].